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THE EFFECT OF SALVIA FRUTICOSA WATER EXTRACT IN ACETIC-ACID-INDUCED
COLITIS IN MICE
Abstract
Inflammatory bowel disease (IBD) including Ulcerative colitis (UC) and Crohn’s disease, is a chronic
condition of the intestine characterized by an uncontrolled inflammatory response. Current biologic
treatments developed to treat IBD are expensive and associated with significant side effects; thus,
alternative approaches are required. Recently, herbal concoctions have emerged as promising intervention.
This study investigates the protective effects of Salvia fruticosa (SF) against acetic acid-induced colitis in
mice, a model of human inflammatory bowel disease (IBD). Mice were divided into four groups (n=3). IBD
was induced with acetic acid (6%). SF was administered by gavage at 1.5ug/kg mimicking folk medicine.
SF treatment was given for 2, 4 & 6 days. After treatment, colons were collected for colonic biochemical
markers, and histopathological evaluation. SF treatment induced enhancement in the colon’s structure
and decreased ulcerations and inflammation. It significantly decreased pro-inflammatory cytokines TNF-α,
IL-17 by 2.1-fold and 0.9-fold respectively at day2 and 6 and IL-6 by 2.8-fold at day 2 & 1.7-fold at day 6.
Also, pro-inflammatory cytokine INF-γ showed a significant 22-fold decrease at day2 in SF-treated colitic
group. Moreover, Myeloperoxidase (MPO) and Malondialdehyde (MDA) levels decreased showing the
anti-oxidant property of the extract. Anti-oxidant Glutathione (GSH) level and anti-inflammatory cytokine
IL-10, remained at normal levels while an increase by 0.9-fold at day 2 and 0.5-fold at day 6 in antiinflammatory cytokine TGF-β in healthy SF-treated groups was significant. Hence, Salvia fruticosa exerts
an anti-inflammatory and anti-oxidant effects against IBD as well as it help healing colon ulcers and
maintain its architecture.
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1. INTRODUCTION
The digestive tract also called the Gastrointestinal tract (GI tract) is a continuous canal that
starts from the mouth down to the anus and comprises the following organs: oral cavity, pharynx,
esophagus, stomach, small intestine and large intestine. Irritable bowel syndrome (IBS),
inflammatory bowel disease (IBD), hemorrhoids, diverticulitis and anal fissures are all diseases
that might affect the GI tract. IBS is a disorder described by altered bowel habits and abdominal
pain (Ceuleers, et al, 2016). IBD is a chronic inflammation of the intestine that majorly comprises
Crohn’s Disease (CD) and Ulcerative Colitis (UC) and is described by the infiltration of
inflammatory cells to the intestinal mucosa (Kim & Cheon, 2017). UC occurs when inflammation
affects part or portion of the large intestine. CD, on the other hand, is not restricted to the large
intestine, but can cause inflammation to any part of the digestive tract (Gohil & Carramusa, 2014).
The symptoms of IBD vary according to the condition severity and inflammation location. Most
common symptoms include diarrhea that may be associated with blood/mucus or constipation as
seen in UC, abdominal pain, weight loss, nausea, and vomiting (McDowell, et al, 2020). IBD
prevalence is higher in North America and Europe than is Asia and Africa (McDowell, et al, 2020).
IBD pathogenesis is multifactorial and involves inappropriate immune response with genetic
susceptibility. Among the genes associated with IBD is the nucleotide-binding oligomerization
domain 2 gene (NOD2) that binds the muramyl dipeptide (MDP) present on most types of bacterial
peptidoglycan inducing immune responses (Zhang & Li, 2014). NOD2 acts as a bacterial sensor
and plays a role in activating the Nuclear Factor Kappa B (NF-KB) signaling pathway. Mutation
in NOD2 results in abnormal immune function (Hanauer, 2006). Oxidative stress, where an
imbalance between free radicals and antioxidant levels occurs, is known to lead to many diseases
including IBD. Enzymes such as the myeloperoxidase (MPO), xanthine oxidase (XO), and
cyclooxygenase (COXs) have been described as major players that induce IBD (Tian et al., 2017).
The intestinal barrier that is made up of intestinal epithelial cells (IECs) and innate immune cells
provides a balance between luminal content and mucosa, any disturbance may lead to UC and CD
(Ramos & Papadakis, 2019). Alterations of the apical junctional complex by means of TNF-α and
IFN-γ leads to the damage of the barrier’s functions upon inflammation, consequent ulcers of the
epithelium may occur. Therefore, it is important to accelerated resealing the epithelial barrier to
minimize IBD risk. Several treatments are used to cure IBD patients including immune
modulators, anti-inflammatory agents, and biologics such as anti-TNF-α therapy that has been
associated with side effects and are highly expensive.
Herbal medicine is a major part of complementary and alternative medicine (CAM) (Li, et
al, 2011) and has attracted attention for research worldwide due to its minimal side effects and
being cheaper than medicinal drugs. Salvia fruticosa (SF), known as Sage, is one of the largest
genus in the family Lamiaceae (Labiatae) with approximately 1000 species distributed worldwide
(Anwar, et al, 2017). Numerous species of Salvia have been used in pharmaceutical industries for
therapeutic research. Salvia fruticosa Miller, also named S. triloba or S. libanotica is a sage species
commonly found in Mediterranean countries. It is also known as East Mediterranean sage or
Lebanese sage (Boukhary, et al, 2016). This herb has been used traditionally as a tea for the remedy
of several pains, menstrual disorders, colds, and bronchitis (Torun, et al, 2015; Boukhary, et al,
2016). S. fruticosa was shown to have a high radical scavenging activity as well as an antiinflammatory activity against carrageenan-induced mouse paw edema (Boukhary, et al, 2016). SF
contains a considerable amount of bioactive components such as polyphenols (hydroxycinnamic
acid derivatives), flavonoids and phenolic diterpenes that contribute to its biological benefits that
include anti-inflammatory, anti-oxidant and anti-microbial activities (Torun, et al, 2015; Anwar,
et al, 2017).
This study aims at investigating the effect of SF water extract on aceticacid induced colitis
in Balb/c female mice. Cytokines were measured, Salvia fruticosa antioxidant activity against IBD
was assessed, and the histological and macroscopical changes were examined.
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2. MATERIALS AND METHOD
2.1. Plant Materials
Samples of Salvia fruticosa plant (herbarium number: ps-14-12) were collected from
Taanayel, Lebanon. The plant was identified by Dr. Georges Tohme, Professor of Taxonomy.
The leaves and the stems were air-dried in the shadow before use.

2.2. Plant Extract Preparation (7%)
The dried leaves were ground into fine powder; 7g were soaked in 100ml boiling
distilled water for 5 minutes. They were left to simmer for 30 minutes then filtered. The
extract was aliquoted and stored at -80°C.

2.3. Experimental Animals
Healthy female Balb/c albino mice (6-8 weeks old) with average weight of 22g were
obtained from the animal house at Beirut Arab University. The mice were grouped into cages
(10 mice per cage) in air conditioned room with temperature between 22°C to 25°C and a
photoperiod of 12L: 12D. Standard laboratory pelleted formula and tap water were provided.
The mice were left to acclimate for one week before the beginning of the experiments.
Animals were fasted for 24 hours before colitis induction using acetic-acid with free access
to tap water. The experimental protocol was approved by the Institutional Review Board at
Beirut Arab University, code number 2020-A-0047-S-M-0407.

2.4. Induction of Colitis
To induce colitis, overnight-fasting mice were intra-rectally injected once with 0.1 ml
of 6% acetic acid (AA) using a 2mm soft polyethylene tubing according to Nakhai, et al.
Mice were held upside down for about 1 min to prevent AA leakage (Nakhai, et al, 2007).

2.5. Animal Treatment
Animals were randomly divided into 4 experimental groups of 9 mice in each group.
• Group N: Normal Group: Animals were left to obtain freely the provided tap water
throughout the study without any treatment.
• Group AA: Animals received 6% acetic acid rectally only once a day 0 with no additional
treatment.
• Group SF: Animals received the aqueous Salvia fruticosa extract by gavage at a dose of
1.5 µL/g for 2, 4, or 6 consecutive days.
• Group AA+SF: Animals received 6% acetic acid rectally once at day 0 and then the
animals were administered the Salvia fruticosa extract 2 hours post induction of colitis.
The extract was given over a period of 2, 4 or 6 days.
Mice were sacrificed the following day after the final dosage given, i.e. after 2, 4 and
6 days which is a convenient duration to be able to assess the effect of the extract against IBD
(Richard, et al, 2011). After dissection, the intestinal tissues were removed, cleaned and
washed using PBS buffer (pH 7.4). Colon length was measured and were sectioned for both
histological and biochemical analysis. The ones used for biochemical analysis were directly
stored at -80°C while the ones used for histological analysis were preserved in 4% formalin
at room temperature.

2.6 Evaluation of Colitis
During the treatment period, the severity of colitis was assessed daily by measuring
the body weight change of each mouse and the disease activity index (DAI). DAI was
calculated by summing up the scores assessed for body weight change, stool consistency and
rectal bleeding according to parameters that are well-established and validated compared to
clinical presentation of human IBD (Cooper et al 1993).
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2.6.1 Body Weight Scoring
0 point= no significant weight loss
1 point= 1-5% weight loss
2 points= 5-10% weight loss
3 points= 10-15% weight loss
4 points= more than 15% weight loss
2.6.2 Stool Consistency and Rectal Bleeding scoring
0 point= normal, no bleeding
2 points= loose stool, slightly bleeding
4 points= watery diarrhea, gross bleeding
DAI score = Body weight score + Stool consistency and rectal bleeding score

2.7 Histological Assessment
After dissection of mice, colon tissues were collected and preserved in 4% Formalin.
Samples were sent to the Histology Center at BAU Faculty of Medicine for processing. H&E
stained slides were examined under light microscope.

2.8 Preparation of Tissue Homogenate
After collecting and cleaning colon samples, the tissues were homogenized in lysis
buffer (pH 7.4) which consists of 5ml PBS, 0.5ml PMSF (1mM) and 0.25ml Triton X-100 at
a ratio of 1g of tissue per 10ml lysis buffer. Colon pieces were homogenized manually on ice
and centrifuged two times at 15,000 rpm for 15 mins at 4°C. The collected supernatants then
stored at -80°C.

2.9 Protein Quantification
After tissue homogenization, protein concentration of each homogenate was
determined using Bradfrod Protein Assay. Bovine Serum Albumin (BSA) was used as a
standard. The absorbance of the developed color was read using a spectrophotometer at
595nm. Protein quantification of the samples was deduced from the BSA standard curve.

2.10 Oxidative Stress Assays
2.10.1 Reduced Glutathione (GSH) Assay
GSH activity (mg GSH/g protein) was measured by a colorimetric assay
using reduced GSH kit according to manufacturer’s instructions (Elabscience, cat
# E-BC-K051). Dithio-dinitrobenzoic acid can react with sulfhydryl compound of
GSH tripeptide to generate a yellow compound.
The optical density was measured at 420nm wavelength.
GSH concentration was calculated using the following formula:
𝑂𝐷 𝑆𝑎𝑚𝑝𝑙𝑒−𝑂𝐷 𝐵𝑙𝑎𝑛𝑘

GSH activity (mg GSH/g protein) =
x Concentration
𝑂𝐷 𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑−𝑂𝐷 𝐵𝑙𝑎𝑛𝑘
-3
of standard (20x10 mmol/L) x GSH molecular weight (307) x Dilution factor (2)
x Dilution factor of sample before tested / concentration of protein (gprot/L).

2.10.2 Myeloperoxidase (MPO) Colorimetric Assay
MPO concentration in colonic tissues was quantified using Myeloperoxidase
(MPO) Colorimetric Assay Kit according to manufacturer’s instructions
(Elabscience, cat # E-BC-K074). MPO reduces hydrogen peroxide to a complex,
where the latter react with o-dianisidine to produce a yellow product. The
supernatant was collected and the absorbance was read spectrophotometrically at
460nm.
MPO concentration was calculated using the following formula:
The amount of MPO in 1ml of sample that catalyzes the decomposition of 1µmol
H2O2 at 37 ̊C for 30 min is defined as 1 unit.
∆A
MPO activity (U/L) =
m x f
11.3 x V x
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(∆A= OD sample-OD control, 11.3= constant, V= volume of sample added to the
reaction (ml), V3=volume of reagent 2 application solution added in sample
preparation step (ml), m= weight of sample (g), f= the dilution factor of sample
before testing).

2.10.3. Malondialdehyde (MDA) Assay
The concentration of MDA of the supernatant of the colonic homogenates
was measured according to the method of Buege & Aust (1978). In brief, 50 l of
the tissue homogenates was added to 100 l TBA reagent (prepared by dissolving
0.025g TBA in 5ml of 20%TCA). The samples were placed in a water bath at 88
˚C for 20 min, left to cool at room temperature and then centrifuged at 1000 rpm
for 15 min. 100 l of the supernatants was added in an ELISA plate to be measured
at 540nm. The MDA content was calculated as TBRAS expressed in terms of
m/mg of protein using a molar extinction coefficient 155 mM-1 cm1 (Chatterjee
& Sil, 2006).
MDA (uM) = (A sample * DF) / (1*Ɛ molar absorptivity).

2.11 Cytokine Assay
All cytokines were quantified similarly using Mouse ELISA kits according to
manufacturer’s instructions (Elabscience). TNF-α, IL-6, IL-10, IFN-γ, TGF-β and IL-17
concentrations were measured in the colonic homogenates. Briefly, standard working
solutions with different concentrations were prepared and 100µL of diluted sample were
added to the anti-body coated 96-well plate. The plate was properly sealed and incubated
at 37°C for 90min. After incubation, the liquid was removed from the well-plate, without
washing, 100µL of 1x Biotinylated Detection Ab working solution was added to each well,
gently mixed, sealed and incubated at 37°C for 60min. Next, 100µL of 1x HRP Conjugate
working solution of the corresponding cytokine was added and incubated at 37°C for
30min. After each incubation, the liquid was removed from the well-plate and washed 3-5
times using washing buffer. 90µL Substrate reagent of the corresponding was added to each
well, liquid coloration was detected and the plate was incubated at 37°C for 15min in
shading light. The reaction was terminated by adding 50µL Stop solution to the wells.
Finally, the plate is read using an ELISA plate reader at 450nm wavelength.

2.12 Statistical Analysis
All statistical analyses were performed using the standard statistical program Graph
Pad Prism Ver. 7. The data are expressed as mean ± standard deviation. Statistical analysis
of the obtained results was analyzed using (ANOVA). Statistical significance is reported
as **** at P-value ≤ 0.0001, *** at P-value ≤ 0.001, ** at P-value ≤ 0.01 and * at P-value
≤ 0.05.

3. RESULTS
3.1 Effect of Extract on Body Weight
The body weight of all mice was measured daily throughout the whole period of the
study. As shown in Figure 1, the normal control group (N Group) showed increase in body
weight of about 9% by day 6. Untreated colitic-mice (Group AA) as well as SF treated coliticmice (Group AA+SF) showed a significant decrease in their body weight of 12.92 % (P-value
0.0002) and 10.76 % (P-value < 0.0001) at day 2 compared to the normal control group
respectively. The first 2 days after colitis induction with acetic acid, the AA group lost 2-3g
daily while AA+SF group lost approximately 1-2g. However, it is worth noting that both
groups started to regain their weights after day 4.

https://digitalcommons.bau.edu.lb/stjournal/vol3/iss2/9
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Fig.1: Effect of extract on body weight. Bar graph showing the percentage change in body weight of
mice in each experimental group for 6 consecutive days. Data represented is mean ± SEM (n=4).
Asterisks shown in the legend represent significance relative to the normal control, (****), (***) and
(*) corresponds to P < 0.0001, P < 0.001and P < 0.05 respectively.

3.2 Effect of Extract on Colon Length
Macroscopic observation of the colons
showed changes in their lengths and
thicknesses. The length of the colons was
measured after dissection from the cecum to
the anus (Figure 2). The healthy group that
received SF had colonic length like the
normal control unlike the length of the
untreated colitic mice that showed a
significant 0.3-fold decrease in length (Pvalue < 0.0001). Upon treating colitic mice
with SF extract, the length of the colon
increased significantly by 0.1-fold (P-value
0.0016) compared to untreated mice (group
SF+AA versus AA group).

Fig.2: Effect of Extract on colon length. The
graph illustrates the colon length in
centimeters of each group. Data represented
is mean ± SEM (n= 3). Asterisks shown on
bars represent significance relative to the
normal control, (****) and (**) corresponds
to P-value < 0.0001 and P-value 0.0016
respectively.

3.3 Effect of SF Extract on Stool Consistency and Rectal Bleeding
To assess the severity of colitis,
Disease Activity Index (DAI) score was
monitored daily by observing stool
consistency, rectal bleeding and change in
body weight for each mouse. At day 2,
untreated colitic-mice showed a significantly
higher DAI score compared to normal mice
(10.5 vs 0, P-value 0.0079). However,
treatment with SF extract induced a
significant decrease in DAI score by 71% (3
vs. 10.5, P-value 0.0465). It is important to
note that DAI score started showing gradual
decrease in colitic groups after day 2 (Figure
3).

Published by Digital Commons @ BAU, 2022

Fig.3: Effect of SF extract on stool
consistency and rectal bleeding. The disease
activity index score of mice over the 6 days
of the experimental study. Data represented
is mean ± SEM (n=4). Asterisks shown on
bars represent significance relative to the
normal control, (*) corresponds to P-value <
0.05.
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3.4 Histopathological analysis
The macroscopic changes of the
colons at different time points are shown in
Figure 4. At day 2, colons of the normal
group and the SF-treated mice were clear
and with no abnormalities as seen in Figure
4-IA and 4-IB respectively. However,
colons of colitic mice showed evident signs
of inflammation including redness
throughout the whole colon, swelling and
shrinkage in colon length with loose stool
(Figure 4-IC). Treating colitic mice with
the aqueous Salvia fruticose extract
induced a decrease in the inflammatory
signs showing less redness and regular size
colon and normal stool consistency (Figure
4-ID).
At day 4, similar results were obtained
as shown in figure 4-II. Clear colonic tissues
were seen in normal and SF mice (Figure 4II A and B respectively). The colons of
untreated colitic mice showed increase in
redness and ulcerations (Figure 4-II C) that
decreased upon SF treatment (Figure 4-II D).
At day 6, the anti-inflammatory effect
of SF was more evident. The colon of SFtreated colitic mice (Figure 4-IIID) was clear
and comparable to that of the normal group
(Figure 4-IIIA), unlike that of the untreated
colitic mice that was still showed signs of
inflammation and shrinkage of the colon’s
length (Figure 4-IIIC). It is worth noting as
well that colon tissues of healthy SF-treated
mice (Figure 4-IIIB) were thicker than colons
of normal mice.
The microscopic analysis verified the
macroscopic analysis of the colons. Figure 5I, 5-II and 5-III shows representative sections
of the colons at day 2, 4 and 6 from all
experimental groups.
Colons section from Normal and SFtreated mice showed normal colonic mucosa
with no distortion in crypt architecture and
numerous goblet cells lining them throughout
the period of study as shown in Figure 5-І, П,
and Ⅲ A and B, respectively.
At day 2, the colons of the untreated
colitic group (Figure 5-ІC) showed
vasodilation, disruption architecture of crypt
(DAC) and infiltration of polymorphonuclear
leukocytes (PMNs) (indicated on figures).
Treatment of colitic group with SF extract
minimized the extent of inflammation as
shown in Figure 5-ID.

https://digitalcommons.bau.edu.lb/stjournal/vol3/iss2/9
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Fig.4: Macroscopic inspection of colon
tissues at days 2 (I), 4 (II) and 6 (III) in all
experimental groups. A shows colon
tissue of normal mice, B shows colon
from SF-treated healthy mice, C shows
colon of colitic untreated mice, and D
shows colon from SF-treated colitic mice.
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At day 4, the colons of untreated colitic mice (Figure 5-П C) showed increase in the
inflammation signs with more crypt distortion, higher PMNs infiltration and goblet cell
loss. Treatment of colitic group with SF extract attenuated these modifications (Figure 5ПD).
At day 6, SF treatment of colitic mice markedly reduce the degree of infiltration and
the architecture of the colon is restored (Figure5-Ⅲ D), the tissue of the colon seemed
regenerated and appeared to be like the normal and SF treated groups (Figure 5-III A and
B). Colitic group showed self-repairing with some inflammation mark ((Figure 5-Ⅲ C) on
day 6 but to a lower extent than previous days.

Fig.5: Histology of the colon tissues at day 2 (І), 4 (П) and 6 (Ⅲ) of all experimental groups.
Panel A shows colon tissue for normal groups, Panel B shows colon tissue for SF-treated
healthy group, Panel C shows colon tissue for colitic untreated group, Panel D shows colon
for SF-treated colitic group. Disrupted architecture of crypt (DAC) and Infiltration of
polymorphonuclear leukocytes (PMN) are seen. (H&E 100X).

3.5 Effect of SF extract on oxidative stress levels
3.5.1 Effect of SF Extract on Reduced Glutathione (GSH) Level
The levels of reduced glutathione (GSH) were measured in the colonic
homogenate of all mice groups at days 2, 4 and 6. At day 2 (Fig. 6-I), a significant
increase in GSH level was observed in the healthy group that received SF extract
by 2.83 folds (P-value 0.005) and the untreated colitic group by 3 folds (P-value
0.003) when compared to normal mice. However, the levels of GSH in colitic mice
that received the SF extract were significantly lower than that of AA Group (Pvalue 0.005) and comparable to normal levels.
At day 4 (Figure 6-II), healthy mice that received SF as well as colitic mice
showed a decrease in GSH level compared to day 2, while SF-treated colitic mice
still shows GSH levels within the normal range (20 mg/mgProt).
At day 6 (Figure 6-III), the GSH level in healthy SF-treated group was still
significantly higher than normal group by 2 folds (P-value 0.014). Colitic untreated
mice showed similar GSH levels as that of day 4, while SF-treated colitic mice
showed a slight increase by 1.3 folds in GSH level when compared to that of day 4.

I

II

III

Fig.6: Effect of SF Extract on Reduced Glutathione (GSH) level. I, II, and III correspond
to GSH level at day 2, 4 and 6 respectively. Data represented is mean ± SEM (n=3).
Asterisks on bars represent significance relative to the control, (**) and (*) correspond to
P-value < 0.01 and P-value < 0.05, respectively.
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3.5.2 Effect of SF Extract on Myeloperoxidase (MPO) level
No significant change in MPO levels were observed at day 2 among all
experimental groups (Fig. 7-I). The highest level of MPO was observed in the
untreated colitic group with an increase of 1.6 folds (P-value 0.41) compared to
normal. SF treatment was able to lower it by 1.22 folds (P-value 0.729).
Similarly, no significant changes were observed at day 4 (Fig. 7-II). The
level of MPO in untreated colitic mice was still higher by 1.3 folds albeit nonsignificantly compared to normal control. SF treatment was also able to lower it
by 1.9 folds. Furthermore, SF treatment decreased MPO further by 1.2 folds
compared to levels at day 2.
At day 6 (Fig 7-III), significant decrease in MPO levels were observed in all
groups compared to the normal control. A decrease by 2.5 folds (P-value 0.029),
3.3-fold (P-value 0.009), and 3.3 folds (P-value 0.017) were observed in SF, AA
and AA+SF groups respectively.

Fig.7: Effect of SF Extract on Myeloperoxidase (MPO) level. I, II and III correspond to
MPO level at day 2, 4 and 6 respectively. Data represented is mean determinations ±
SEM (n=3). Asterisks on bars represent significance relative to the control, (**) and (*)
corresponds to P-value < 0.01 and P-value < 0.05, respectively.

3.5.3 Effect of SF Extract on Malondialdehyde (MDA) Level
MDA levels were measured in colonic homogenates of all mice at day 2, 4
and 6 (Figure 8). The highest level of MDA was observed at day 2 in the untreated
colitic group with a significant 1.3-fold increase (P-value 0.0159) compared to
normal. Upon SF treatment, MDA level significantly decreased by 0.7-fold (Pvalue 0.0308) compared to untreated colitic group, while at day 4 and 6 no
significant changes were observed in MDA levels.

Fig.8: Effect of SF on Malondialdehyde (MDA) level. I, II, and III correspond to MDA
level at day 2, 4 and 6 respectvely. Data represented is mean ± SEM (n=3). Asterisks on
bars represent significance relative to the control, (*) correspond to P-value < 0.05.
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3.6 Effect of SF extract on Levels of Inflammation Markers
3.6.1 Effect of SF extract on TNF-α level
At day 2 (Fig 9-I), SF treatment in colitic mice induced a significant 1.6-fold
decrease in TNF-α levels compared to the untreated colitic group (P-value 0.047).
At day 4 (Fig. 9-II), no significant changes in the levels TNF-α of all groups
were observed compared to the normal control. However, the levels were overall
slightly lower compared to the levels of day 2 and where the SF-treated colitic mice
exhibited the least levels.
At day 6 (Fig. 9-III), similar results were obtained where no significant
changes in TNF-α levels were observed in SF and AA mice compared to control.
The only significant decrease was observed in SF-treated colitic mice (2.1-fold, Pvalue 0.043) compared to normal group.

Fig. 9: Effect of SF extract on TNF-α level. I, II and III correspond to TNF-α level at
day 2, 4 and6 respectively. Data represented is mean ± SEM (n=3). Asterisks on bars
represent significance relative to the control, (**) and (*) corresponds to P-value < 0.01
and P-value < 0.05, respectively.

3.6.2. Effect of SF extract on IL-6 level
At day 2 (Fig. 10-I), SF treatment of colitic mice induced a significant 2.8fold decrease in IL-6 levels compared to untreated colitic mice (P-value 0.023).
At day 4 (Fig. 10-II), all experimental groups showed lower concentration
of IL-6 compared to day 2. However, no significant changes were observed
among the groups.
At day 6 (Fig. 10-III), a significant 1.7-fold decrease in IL-6 levels was
observed in SF-treated colitic mice compared to untreated ones (P-value 0.0006).

Fig. 10: Effect of SF extract on IL-6 level. I, II and III correspond to IL-6 level at day
2, 4, and 6 respectively. Data represented is the mean ± SEM (n=3). Asterisks on bars
represent significance relative to the control, (***), (**) and (*) corresponds to P-value
< 0.001, P-value < 0.01 and P- value < 0.05, respectively.
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3.6.3. Effect of SF extract on IFN-γ level
At day 2 (Fig. 11-I), a significant 2.2-fold decrease was observed in SFtreated colitic mice compared to the untreated colitic mice (P-value 0.019).
Similar results were seen at day 4 (Fig. 11-II). The untreated colitic mice
showed significant higher levels of IFN-γ compared to normal mice (2 folds, Pvalue 0.041). SF treatment of colitic mice caused a significant 2.7-fold decrease
in IFN-γ levels compared to untreated ones (P-value 0.015).
At day 6 (Fig. 11-III), the levels of IFN-γ was significantly lower in all
experimental groups compared to normal control (P-value 0.012), with SF treated
colitic mice exhibiting the lowest levels. The levels of IFN-γ decreased to lower
values compared to day 4.

Fig.11: Effect of SF extract on IFN-γ level. I, II and III correspond to IFN-γ level at day
2, 4 and 6 respectively. Data represented is mean ± SEM (n=3). Asterisks on bars
represent significance relative to the control, (*) corresponds to P-value < 0.05.

3.6.4. Effect of SF extract on IL-10 level
At day 2 (Fig. 12-I), a significant increase in the concentration of IL-10 was
observed in SF-treated healthy mice by 6.8 folds and untreated colitic mice by 6
folds compared to normal mice (P-value < 0.001). SF treatment of colitic mice
induced a significant 3.5 folds decrease in IL-10 levels compared to untreated
colitic mice (P-value < 0.001).
At day 4 (Fig. 12-II), the level of IL-10 dramatically decreased by 2.3 folds
in untreated colitic mice compared to normal mice (P-value 0.029). Similarly, IL10 level significantly decreased in SF-treated colitic group compared to normal
group (P-value 0.017).
At day 6 (Fig. 12-III) no significant change was noticed between groups as
well as when compared to the levels at day 4.

Fig.12: Effect of SF extract on IL-10 level. 12-I corresponds to IL-10 level at day 2, 12-II
corresponds to IL-10 level at day 4 and 12-III corresponds to IL-10 level at day 6. Data
represented is mean ± SEM (n=3). Asterisks on bars represent significance relative to the
control, (***) and (*) corresponds to P-value < 0.001 and P-value < 0.05, respectively.
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3.6.5. Effect of SF extract on IL-17 Level
At day 2 (Fig 13-I), the level of IL-17 significantly increased in the untreated
colitic group by 1.6-fold (P-value 0.004) compared to the normal group. Upon
treatment of colitic mice with the SF extract, the level of IL-17 decreased
significantly by 1.6-fold (P-value 0.004) and was comparable to that of the normal
control mice.
At day 4 (Figure 13-II), no significant changes were seen among the groups.
At day 6 (Figure13-III), a significant 0.5-fold (P-value 0.037) increase in IL17 level was observed in healthy mice administered with SF extract. Furthermore,
a significant decrease by 0.9-fold (P-value 0.049) was obtained compared to the
normal group.

Fig.13: Effect of SF extract on IL-17 level. Panel I correspond to IL17 level at day 2,
Panel II corresponds to IL-17 level at day 4 and Panel III corresponds to IL-17 level at
day 6. Data represented is mean ± SEM (n=3). Asterisks on bars represent significance
relative to the control, (**) and (*) corresponds to P-value < 0.01 and P-value < 0.05,
respectively.

3.6.6. Effect of SF extract on TGF-β Level
At day 2 (Figure 14-I), a significant increase in the concentration of
TGF-β was observed in SF-administered healthy mice by 0.9-fold (P-value
0.006) and untreated colitic mice by 0.6-fold (P-value 0.024) compared to
normal mice. SF treatment of colitic mice induced a significant 1.4-fold
decrease in TGF-β level compared to untreated colitic mice (P-value 0.005).
At day 4 (Figure 14-II), no significant change was noticed between
groups. However, the level of TGF-β among groups on day 4 was lower than
the level of TGF-β in day 2.
At day 6 (Figure 14-III), a significant increase in TGF-β level in SFtreated healthy group by 0.5-fold (P-value 0.003) and a decrease in SF-treated
colitic group by 0.8-fold (P-value 0.006) in comparison with normal group.
Also, TGF-β level significantly decreased in SF-treated colitic group by 0.7fold compared to untreated colitic group (P-value 0.012).

Fig. 14: Effect of SF extract on TGF-β level. Panel I correspond to TGF-β level at
day 2, Panel II corresponds to TGF-β level at day 4 and Panel III corresponds to
TGF-β level at day 6. Data represented is mean ± SEM (n=3). Asterisks on bars
represent significance relative to the control, (**) and (*) corresponds to P-value <
0.01 and P-value < 0.05, respectively.
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4. DISCUSSION
IBD including Ulcerative colitis and Crohn’s disease is an inflammatory disease
characterized by chronic relapsing intestinal inflammation, which can lead to weight loss,
abdominal pain, diarrhea, and blood in stool, accompanied with macroscopic colonic alteration
such as ulceration. The disease incidence is raising worldwide and current treatments, like antiinflammatory agents, immune-modulators, biologics and CAM, have been associated with
multiple side effects such as cytotoxicity, susceptibility to infectious diseases, bone marrow
suppression and allergic reactions. Herbal medicine had grabbed researchers’ attention due to its
association with less side effects as well as its effectiveness against multiple diseases. Salvia
fruticosa is an East Mediterranean plant that has been used in treating diseases due to its
antioxidant and anti-inflammatory effects (Boukhary et al., 2015 & Bassil, et al., 2016). Studies
have shown that ulcerative colitis can be induced in animals treated with acetic acid mimicking
the disease in humans (Low, et al., 2013: Fabia, et al 1992). In the present study, we demonstrate
the anti-inflammatory and antioxidant effect of SF water extract in colitic mice induced by 6%
acetic acid.
Treatment with SF water extract showed improvement in body weight, colon length, DAI
score, and in histopathological assessment. A slightly higher weight loss was observed in colitic
SF-treated compared to the untreated colitic mice at day 6. These results build on existing evidence
where SF increased body weight in alloxan-induced diabetic mice (Raafat, et al, 2013). The disease
severity assessed by DAI score was noticeably improved in the colitic group that received SF. As
for the consistency of stool, it was harder and more compacted compared to the untreated group
that showed watery & bloody stool. Moreover, colon length is inversely related to the severity of
inflammation, the observed findings showed a shortening of colon length in acetic acid-induced
colitis; while, in SF-treated colitic groups, intestinal length was effectively restored.
Macroscopic and microscopic observations confirmed the therapeutic effect of Salvia
fruticosa extract on acetic acid induced colitis. The histopathological observations showed that SF
treatment led to reduction of the inflammatory response. The cells regenerated and the architecture
of the colon was restored and re-organized as opposed to the untreated group that showed
noticeable PMN infiltrations and crypts disruption.
There are several anti-oxidative mechanisms within the GI tract including the enzymes
catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx), along with nonenzymatic scavengers, such as glutathione. Recently, it has been suggested that peripheral
immune cells in patients with active CD produce higher levels of SOD activity and H2O2 (Beltran
et al. 2010). Salvia fruticosa, in addition to its role as a tissue regenerative agent, is known to
possess an antioxidant role. The level of reduced GSH, MPO and MDA were measured in all
experimental groups. The MDA level in our study showed a significant increase in colitic mice at
day 2 compared to the control group. In contrast, SF treatment induced a decreased MDA level in
colitic mice during that period. GSH content was significantly increased in healthy mice that
administered SF at day 2, then it decreased afterwards to normal level, while SF treatment in colitic
mice showed approximately normal levels of GSH throughout the whole experimental duration
implying that SF treatment during colitis helps to prevent the changes in GSH levels. Similar
observations were obtained by Hamza et al., where SF was found to normalize GSH content and
prevent MDA elevation in liver, heart and kidney of diabetic rats. As for myeloperoxidase (MPO),
its level increased in colitic mice compared to control group, however SF treatment appeared to
decrease its activity. These results are comparable with a previous study that has proven the antioxidant activity of SF in streptozotocin-induced diabetic rats (Hamza, et al, 2016). It was
suggested that the SF anti-oxidant activity is mainly attributed to its excessive polyphenols and
terpenes content (Ravipati, et al, 2012; Fu, et al, 2013).
The anti-inflammatory potential of SF is surely related to its strong antioxidant. To achieve
this conclusion, the levels of inflammatory markers TNF-α, IL-6, IL-10, IFN-γ, TGF-β and IL-17
that change according to inflammation severity were measured. As expected, induction of colitis
by acetic acid significantly increases the level of pro-inflammatory cytokines (TNF-α, IL-6, IFNγ and IL-17) compared to the normal, ultimately, due to the activation of monocytes and
macrophages in intestinal inflammation (Fournier, & Parkos, 2012). SF treatment decreased proinflammatory cytokines (TNF-α, IFN-γ, IL-6 and IL-17) in SF-treated colitic group throughout
the study period. SF was shown to decrease and suppress pro-inflammatory cytokine TNF-α and
IL-6 up to 85% and 56% respectively in LPS-challenged Balb/C mice (Bzour, et. al., 2011). It was
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shown that carnosol extracted from SF significantly reduced TNF-α cytokine in inflamed skin
(Yeo,et al., 2018). Other SF components such as α-thujone and β-thujone reduce the production
of the proinflammatory cytokines TNF-α, IL-1β, and IL-6 (Siveen & Kuttan, 2011). As for antiinflammatory cytokines, SF induce a significant increase in TGF-β in healthy SF-treated groups
as compared to the normal, also, a significant decrease in TGF- β production was shown in colitic
group treated with SF compared to untreated colitic group at day 2 and day 6. Colitic mice that
were given SF treatment showed a significant decrease in IL-10 production as compared to the
untreated colitic mice (P < 0.001). The results confirm that inflammation in the treated group has
decreased upon SF treatment. The anti-inflammatory activity of SF may be partly attributed to the
overall effects of the phenolics and other plant constituents having potent anti-inflammatory
actions similar to diclofenac. SF has been tested for its anti-inflammatory effect and both the aerial
parts and the roots exhibited significant protection against carrageenan-induced mouse paw edema
(Boukhary, et al 2016).
Salvia officinalis is a plant that belongs to the same family as Salvia fruticosa
(Labiatae/Lamiacea). This herb was proven to possess similar properties as SF. Pharmacological
findings for S. officinalis that are reported include anticancer, anti-inflammatory, anti-oxidant and
antimicrobial effects (Ghorbani, A., & Esmaeilizadeh, M., 2017). Noteworthy, S. fruticosa has a
similar chemical profile as S. officinalis implying that it might possess similar activities that should
be investigated (Couladis, M. & Koutsaviti, A., 2017). Previous studies have shown the presence
of rosmarinic acid, carnosol, and/or carnosic acid in Salvia officinalis, major components of SF
(Vieira, et al 2020).
After exploring the anti-inflammatory, anti-oxidant and regenerative effect of Salvia
fruticosa, our findings suggest that SF is one of the herbal medicines that have a potential in
treating IBD.

5. CONCULSIONS
Upon treating acetic-acid induced colitic mice with 1.5µL/g of Salvia fruticosa aqueous
extract for 2, 4 and 6 days. Salvia fruticosa aqueous extract induced enhancement in the colon’s
structure and decreased ulcerations and inflammation. It significantly decreased inflammation as
assessed through the measurement of the pro-inflammatory cytokines. TNF-α, IFN-γ, IL-6 and IL17 were decreased in the colitic group treated with SF compared to the untreated one at day 2, 4
and 6. Moreover, Myeloperoxidase (MPO) and Malondialdehyde (MDA) levels decreased upon
treatment showing the anti-oxidant property of the extract. Anti-oxidant Glutathione (GSH) level
and anti-inflammatory cytokine IL-10, remained at normal levels during the treatment process. SF
induced a significant increase in anti-inflammatory cytokine TGF-β in healthy SF-treated groups.
Hence, Salvia fruticosa exerts an anti-inflammatory and anti-oxidant effects against IBD as well
as it help healing colon ulcers and maintain its architecture.
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